Table 2.
Results of meta-analysis for MMP-1-1607 1G/2G polymorphism and bladder cancer risk
Comparison | Test of association | Model | Test of heterogeneity | |||
---|---|---|---|---|---|---|
OR | 95 % CI | P | P | I 2 | ||
2G vs. 1G | 1.17 | 0.98–1.39 | 0.083 | R | 0 | 88.2 |
2G2G vs. 1G1G | 1.26 | 0.95–1.67 | 0.103 | R | 0 | 83.8 |
1G2G vs. 1G1G | 1.02 | 0.89–1.16 | 0.799 | R | 0.035 | 65.0 |
2G2G vs. 1G2G/1G1G | 1.44 | 1.05–1.97 | 0.022 | R | 0.003 | 79.0 |
2G2G/1G2G vs. 1G1G | 1.06 | 0.95–1.20 | 0.307 | R | 0.001 | 82.8 |
OR odds ratio, CI confidence interval, F fixed effect model, R random effect model